87171-72-0

Upstream product

• 68115-82-2 benzyl 2,3,6-tri-O-acetyl-4-O-(2,3-di-O-acetyl-4,6-O-benzylidene-β-D--galacto-pyranosyl)-β-D-glucopyranoside 
• 87171-68-4 2,3,6-tri-O-acetyl-4-O-(2,3-di-Oacetyl-4-O-benzoyl-6-bromo-6-deoxy-β-D-galactopyranosyl)-D-glucopyranose 
• 87171-70-8 1,2,3,6-tetra-O-acetyl-4-O-(2,3-di-O-acetyl-4-O-benzoyl-6-bromo-6-deoxy-β-D-galactopyranosyl)-D-glucopyranose 

Downstream Products

• 87171-73-1 2,3,6-tri-O-acetyl-4-O-(2,3-di-O-acetyl-4-O-benzoyl-6-bromo-6-deoxy-β-D-galactopyranosyl)-1-thio-β-D-glucopyranose 
• 87171-74-2 6-(5-cholesten-3β-yloxy)hexyl 2,3,6-tri-O-acetyl-4-O-(2,3-di-O-acetyl-4-O-benzoyl-6-bromo-6-deoxy-β-D-galactopyranosyl)-1-thio-β-D-glucopyranoside 

Relevant academic research and scientific papers

SYNTHESIS OF 6-(5-CHOLESTEN-3Β-YLOXY)HEXYL 4-O-(6-DEOXY-Β-D-GALACTOPYRANOSYL)-1-THIO-Β-D-GLUCOPYRANOSIDE AND DERIVATIVES THEREOF FOR in vivo LIPOSOME STUDIES

6-(5-Cholesten-3β-yloxy)hexyl 4-O-(6-deoxy- and 3,6-anhydro-β-D-galactopyranosyl)-1-thio-β-D-glucopyranoside were prepared from benzyl 4-O-β-D-galactopyranosyl-β-D-glucopyranoside, and incorporated into phospholipid vesicles.When injected intravenously in